某三甲医院建立《输液顺序标签标注质量标准》的实践
|
摘要
目的:建立静脉用药集中调配《输液顺序标签标注质量标准》,指导调控输液顺序提高患者用药安全性和有效性。方法:设计并建立用药安全性和有效性相关的8个药学信息子数据库,采用WCF数据通道技术和SOA设计方法实现医嘱用药的智能提示,制定《输液顺序标签标注质量标准》指导输液顺序标签标注。结果:每一个子数据库,按提示标注输液顺序的患者占有提示的患者百分比(标注患者/提示患者)分别为:"频次"55.28%,"辅药"49.49%,"时限"(≤4 h)"、"禁忌"、"相互"100%,"时辰"76.53%,刺激"98.36%,"预防(治疗)"93.94%;基于提高用药安全性和有效性标注输液顺序的患者占总住院患者66.33%。结论:建立《输液顺序标签标注质量标准》指导输液顺序的标注,可提高用药安全性和有效性。
OBJECTIVE To explore and establish "quality standard of infusion sequence labeling" in pharmacy intravenous admixture services(PIVAS), and to improve medication safety and effectiveness through regulation of infusion sequence. METHODS Eight sub-databases of pharmaceutical information related to medication safety and efficacy were designed and established. Windows Communication Foundation(WCF) and Service-Oriented Architecture(SOA) were used to realize the intelligent prompt of prescribed drugs. "Quality standard of infusion sequence labeling" was established to guide infusion sequence labeling. RESULTS In each sub-database, the percentage of patients with tags(labelled patients/prompted patients) by prompting the infusion sequence were: "Dosing frequency" at 55.28%, "Auxiliary" at 49.49%, "Time limit(≤4 h)" at 100%, "Incompatibility" at 100%, "Chronopharmacology" at 76.53%, "Interaction" at 100%, "Irritative" at 98.36%, and "Preventive(therapeutic)" at 93.94%, respectively; patients labelled with infusion sequence based on improved medication safety and effectiveness accounted for 66.33% of the total hospitalized patients. CONCLUSION Through establishment of "quality standard of infusion sequence labeling" for guiding infusion sequence regulating and labeling, the safety and effectiveness of medication can be improved.
OBJECTIVE To explore and establish "quality standard of infusion sequence labeling" in pharmacy intravenous admixture services(PIVAS), and to improve medication safety and effectiveness through regulation of infusion sequence. METHODS Eight sub-databases of pharmaceutical information related to medication safety and efficacy were designed and established. Windows Communication Foundation(WCF) and Service-Oriented Architecture(SOA) were used to realize the intelligent prompt of prescribed drugs. "Quality standard of infusion sequence labeling" was established to guide infusion sequence labeling. RESULTS In each sub-database, the percentage of patients with tags(labelled patients/prompted patients) by prompting the infusion sequence were: "Dosing frequency" at 55.28%, "Auxiliary" at 49.49%, "Time limit(≤4 h)" at 100%, "Incompatibility" at 100%, "Chronopharmacology" at 76.53%, "Interaction" at 100%, "Irritative" at 98.36%, and "Preventive(therapeutic)" at 93.94%, respectively; patients labelled with infusion sequence based on improved medication safety and effectiveness accounted for 66.33% of the total hospitalized patients. CONCLUSION Through establishment of "quality standard of infusion sequence labeling" for guiding infusion sequence regulating and labeling, the safety and effectiveness of medication can be improved.
引文
[1] Kufel WD,Miller CD,Johnson PR,et al.Y-site Incompatibility Between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam:Do Current Compatibility Testing Methodologies Tell the Whole Story?[J].Hosp Pharm,2017,52(2):132-137.
[2] Feng X,Yu LJ,Deng GX,et al.Study on the compatible stability of Omeprazole Sodium for injection with 20 kinds of common TCM injections[J].China Med Herald(中国医药导报),2018,15(27):154-157.
[3] Lu XL,Song XW,Yu ZY,et al.Pharmaceutical incompatibility and preventive measures for potassium aspartate and magnesium aspartate injection in combined intravenous medication[J].Central South Pharm(中南药学),2018,16(10):1472-1475.
[4] Gong XY,Cheng J,Li CH,et al.Investigation and analysis of antibacterial drug by intravenous infusion in in-hospital patients[J].Anhui Med Pharm J(安徽医药),2017,21(05):939-942.
[5] Du R,Yuan H,Yu X.Stability of Reduning,Tanreqing and Xiyanping injections in clinical use[J].Chin Hosp Pharm J(中国医院药学杂志),2016,36(13):1095-1099.
[6] Qiu J,Deng TT,Chen C,et al.Exploration of regulating infusion administration sequence by an intelligent prompt system in pharmacy intravenous admixture services[J].Chin J Hosp Admin(中华医院管理杂志),2018,34(8):674-676.
[7] Zhang B,Li XL.Adherence to clinical guidelines for prophylaxis of chemotherapy induced nausea and vomiting[J].Chin Hosp Pharm J(中国医院药学杂志),2018,38(12):1325-1329.
[8] Pu B,Sun B,Xie FD.Investigation on rationality of chemotherapy drug use in tumor patients and pharmaceutical care[J].China Pharm(中国药房),2016,27(05):706-708.
[9] Wang CC,Peng Y,Chen FR,et al.Combination chemotherapy and medication order[J].China Pharm(中国药房),2013,24(26):2470-2472.
[10] ]Cheng J,Gong XY,Li CH,et al.Analysis of intravenous transfusion of antineoplast-ic agents in a hospital[J].Chin Hosp Pharm J(中国医院药学杂志),2016,36(24):2213- 2217.
[11] Feng R,Zheng Y,Gao YQ,et al.Analysis of sequential administration and chronolo-gical administration by pharmacists in pharmacy intravenous admixture services[J].Chin J Clin Rational Drug Use(临床合理用药),2016,9(10):93-94.
[2] Feng X,Yu LJ,Deng GX,et al.Study on the compatible stability of Omeprazole Sodium for injection with 20 kinds of common TCM injections[J].China Med Herald(中国医药导报),2018,15(27):154-157.
[3] Lu XL,Song XW,Yu ZY,et al.Pharmaceutical incompatibility and preventive measures for potassium aspartate and magnesium aspartate injection in combined intravenous medication[J].Central South Pharm(中南药学),2018,16(10):1472-1475.
[4] Gong XY,Cheng J,Li CH,et al.Investigation and analysis of antibacterial drug by intravenous infusion in in-hospital patients[J].Anhui Med Pharm J(安徽医药),2017,21(05):939-942.
[5] Du R,Yuan H,Yu X.Stability of Reduning,Tanreqing and Xiyanping injections in clinical use[J].Chin Hosp Pharm J(中国医院药学杂志),2016,36(13):1095-1099.
[6] Qiu J,Deng TT,Chen C,et al.Exploration of regulating infusion administration sequence by an intelligent prompt system in pharmacy intravenous admixture services[J].Chin J Hosp Admin(中华医院管理杂志),2018,34(8):674-676.
[7] Zhang B,Li XL.Adherence to clinical guidelines for prophylaxis of chemotherapy induced nausea and vomiting[J].Chin Hosp Pharm J(中国医院药学杂志),2018,38(12):1325-1329.
[8] Pu B,Sun B,Xie FD.Investigation on rationality of chemotherapy drug use in tumor patients and pharmaceutical care[J].China Pharm(中国药房),2016,27(05):706-708.
[9] Wang CC,Peng Y,Chen FR,et al.Combination chemotherapy and medication order[J].China Pharm(中国药房),2013,24(26):2470-2472.
[10] ]Cheng J,Gong XY,Li CH,et al.Analysis of intravenous transfusion of antineoplast-ic agents in a hospital[J].Chin Hosp Pharm J(中国医院药学杂志),2016,36(24):2213- 2217.
[11] Feng R,Zheng Y,Gao YQ,et al.Analysis of sequential administration and chronolo-gical administration by pharmacists in pharmacy intravenous admixture services[J].Chin J Clin Rational Drug Use(临床合理用药),2016,9(10):93-94.